[Comment on the contribution by P. Altmeyer, D. Seifarth, M. Bacharach-Buhles: "High dose intravenous immunoglobulin (IVIG) therapy in therapy refractory ANCA-negative necrotizing vasculitis].
Krämer
K U
KU
Klinik für Dermatologie und Allergologie, Zentralklinikum Augsburg.
Balda
B R
BR
D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D010488:Polyarteritis Nodosa / Q000175:diagnosis / Q000188:drug therapy*
D019268:Antibodies, Antineutrophil Cytoplasmic